https://www.siliconvalley.com/2024/09/18/ozempic-very-likely-to-face-drug-price-negotiations-novo-says/

By Gerry Smith and Madison Muller | Bloomberg

Ozempic, the blockbuster diabetes shot made by Novo Nordisk A/S, is “very likely” to be one of the next drugs to have its price slashed in bargaining with the US government, a company executive said.